<i>UGT1A1</i> genotypes of 27 East Asian Crigler–Najjar syndrome type II cases, as reported in NCBI PubMed, EMBASE (using the search-term “Crigler–Najjar” between January 1992, when <i>UGT1A1</i> was firstly identified, and November 2014), HGMD (CM062020, CM062020, CM941960, CD941964, CM931125, CM961403, CM972924, CM983519, CM002648, CM002649, CM002415, CD002537, CD014669, CM022853, CM051658, CM051659, CM051661, CM051662, CM051665, CM051666, CS051705, CS051706, CM066253, CM062021, CM062019, CD062241, CM067485, CM067484, CM100072, CM100073, CD100074, CM098937), and OMIM databases (191740).

The UGT1A1 enhancer was not sequenced in all cases; exclusions were patients S21, who carried a wild-type enhancer, and S27, who carried a homozygous c.-3279T>G variant in the enhancer. The UGT1A1 promoter in patients S6, S10, S11, S12, S16, S19 was also not sequenced; patients S1, S2, and S3 are sisters; patients S7, S8, S9, and S18 (three males and one female) are subjects from the same study, and their detailed clinical data were not available to the authors: their mean age and bilirubin levels are 62.8 years and 236.8 μmol/L, respectively. The age of patient S10, the gender of patient S18, and the gender and age of patient S26 were not available. F = female; M = male; TB = total bilirubin; NA = not available UGT1A1 genotypes of 27 East Asian Crigler–Najjar syndrome type II cases, as reported in NCBI PubMed, EMBASE (using the search-term “Crigler–Najjar” between January 1992, when UGT1A1 was firstly identified, and November 2014), HGMD (CM062020, CM062020, CM941960, CD941964, CM931125, CM961403, CM972924, CM983519, CM002648, CM002649, CM002415, CD002537, CD014669, CM022853, CM051658, CM051659, CM051661, CM051662, CM051665, CM051666, CS051705, CS051706, CM066253, CM062021, CM062019, CD062241, CM067485, CM067484, CM100072, CM100073, CD100074, CM098937), and OMIM databases (191740).